NasdaqCM - Nasdaq Real Time Price USD
SCYNEXIS, Inc. (SCYX)
5.33 -0.31 (-5.50%)
At close: June 1 at 4:00:00 PM EDT
5.12 -0.21 (-3.95%)
After hours: June 1 at 7:45:33 PM EDT
Chart Range Bar
Loading chart for SCYX
Chart does not reflect overnight price.
- Previous Close
5.64 - Open
5.61 - Bid 4.04 x 200
- Ask 6.48 x 200
- Day's Range
5.03 - 5.62 - 52 Week Range
4.52 - 10.48 - Volume
161,437 - Avg. Volume
73,548 - Market Cap (intraday)
423.429M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-3.84 - Earnings Date May 11, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
33.55
Recent News
View More
Performance Overview
Trailing total returns as of 6/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
SCYX
5.42%
S&P 500 (^GSPC)
11.02%
1-Year Return
SCYX
23.86%
S&P 500 (^GSPC)
28.56%
3-Year Return
SCYX
74.57%
S&P 500 (^GSPC)
80.05%
5-Year Return
SCYX
93.32%
S&P 500 (^GSPC)
80.86%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/1/2026
Market Cap
52.93M
Enterprise Value
-4.27M
Trailing P/E
--
Forward P/E
3.72
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.65
Price/Book (mrq)
1.28
Enterprise Value/Revenue
0.06
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-120.51%
Return on Assets (ttm)
-20.96%
Return on Equity (ttm)
-53.39%
Revenue (ttm)
20.34M
Net Income Avi to Common (ttm)
-24.52M
Diluted EPS (ttm)
-3.84
Balance Sheet and Cash Flow
Total Cash (mrq)
59.26M
Total Debt/Equity (mrq)
4.99%
Levered Free Cash Flow (ttm)
2.65M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.7923
-0.71%
Mkt Cap 73.669M
Industry Drug Manufacturers—Specialty & Generic
1.1900
+1.71%
Mkt Cap 36.744M
Industry Drug Manufacturers—Specialty & Generic
1.0200
0.00%
Mkt Cap 273.623M
Industry Drug Manufacturers—Specialty & Generic
3.2500
-2.99%
Mkt Cap 38.885M
Industry Drug Manufacturers—Specialty & Generic
2.3900
-5.94%
Mkt Cap 38.637M
Industry Drug Manufacturers—Specialty & Generic
1.6800
0.00%
Mkt Cap 7.49M
Industry Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.